Login to Your Account



Earnings Roundup


Friday, May 4, 2012
• Onyx Pharmaceuticals Inc., of South San Francisco, reported a wider-than-expected loss for the first quarter, posting a non-GAAP net loss of $43.5 million, or 68 cents per share, compared to consensus estimates predicting a loss of $63 cents per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription